Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery

Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery

The study aim is to assess polyethylene glycol (PEG) coated collagen patch (Hemopatch) on the quality of drainage after surgery, the length of hospital stay, the number of reoperations due to haemorrhage and treatment cost. The study will be conducted in 200 patients undergoing Coronary Artery Bypass Grafting (CABG) with the use of extracorporeal circulation and Internal mammary Artery (IMA) harvesting. Traditional method of haemostasis will be applied in 100 patients and Hemopatch will be additionally used in 100 subjects to prevent haemorrhage after IMA harvesting and sternum closure.

Inclusion Criteria:

• coronary heart disease CHD (mammary harvesting)
• age>18
• informed consent

Exclusion Criteria:

• any condition that exclude patient from standard CABG procedure
• additional cardiac procedure to be conducted on subject in addition to CABG